Post-approval studies (Phase 4)UnknownNCT01023633What this trial is testingOPTIMOX1 in Chinese mCRC PatientsWho this might be right forColorectal Cancer Nanjing Medical University 300
Testing effectiveness (Phase 2)Looking for participantsNCT07407465What this trial is testingUpfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.Who this might be right forColorectal CancerColorectal AdenocarcinomaRectal Adenocarcinoma+4 more Gruppo Oncologico del Nord-Ovest 42
Not applicableUnknownNCT04917276What this trial is testingTreatment Response Prediction System of mCRC Patients Based on CTCWho this might be right forColorectal Cancer Stage IVCirculating Tumor Cell Fudan University 100
Early research (Phase 1)Study completedNCT01966289What this trial is testingSGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)Who this might be right forMetastatic Colorectal Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243938What this trial is testingPhase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)Who this might be right forLocally Advanced Rectal Cancer (LARC)Locally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaMetastatic Colorectal Cancer (mCRC)+1 more Tao Zhang 70
Not applicableStudy completedNCT05839951What this trial is testingAn Observational Study Called STAR-T to Learn More About the Sequential Treatment With Regorafenib and TAS-102 in Adults With Metastatic Colorectal Cancer Under Real World ConditionsWho this might be right forMetastatic Colorectal Cancer (mCRC) Bayer 818
Testing effectiveness (Phase 2)Ended earlyNCT01464593What this trial is testingPhase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC)Who this might be right forColon Cancer Liver Metastasis Imunon 2
Early research (Phase 1)Looking for participantsNCT06147037What this trial is testingA Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid TumoursWho this might be right forAdvanced Solid TumorMetastatic Colorectal CarcinomaHead and Neck Squamous Cell Carcinoma+4 more AstraZeneca 70
Not applicableUnknownNCT04230018What this trial is testingThe Gene Profiles of Primary and Heterogeneous Metastases of Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Sun Yat-sen University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06485713What this trial is testingEfficacy and Safety of Trifluridine/Tipiracil Combined With Fufuquitinib for Third-line Treatment of mCRCWho this might be right forMetastatic Colorectal CancerDrug Therapy First Affiliated Hospital of Wenzhou Medical University 200
Testing effectiveness (Phase 2)Looking for participantsNCT06149481What this trial is testingPhase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)Who this might be right forMetastatic Colorectal Cancer National Cancer Institute (NCI) 60
Not applicableEnded earlyNCT01074333What this trial is testingAn Observational Study of Erbitux® in Patients With Metastatic Colorectal Cancer (mCRC) Refractory to Irinotecan-containing TreatmentWho this might be right forColorectal Neoplasm Merck KGaA, Darmstadt, Germany 146
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06835179What this trial is testingSBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.Who this might be right forUnresectable Metastatic Colorectal CancerMicrosatellite Stable (MSS) Colorectal Cancer (CRC)RAS-mutant Colorectal Cancer The First Affiliated Hospital with Nanjing Medical University 28
Early research (Phase 1)UnknownNCT05155124What this trial is testingSafety of Cetuximab and Trifluridin Tipiracil as the Third-line Therapy in the RASwt mCRCWho this might be right forColorectal Neoplasms Malignant Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 6
Testing effectiveness (Phase 2)Looking for participantsNCT07255664What this trial is testingA FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PCWho this might be right forMetastatic Colorectal CancerProstate Cancer MetastaticProstate Cancer Locally Advanced Curacell Holding AB 12
Testing effectiveness (Phase 2)UnknownNCT03912857What this trial is testingCamrelizumab(SHR-1210) Combined With Apatinib in the Treatment of Advanced Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Sun Yat-sen University 50
Not applicableLooking for participantsNCT07043387What this trial is testingStreamlining Radioembolization for CCC and Metastatic Liver CancerWho this might be right forMetastatic Colorectal Carcinoma (mCRC)Metastatic Liver CancerCholangiocarcinoma Seoul National University Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT07011576What this trial is testingFruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (mCRC)Who this might be right forColon CancerRectal CancerColorectal Cancer+1 more SCRI Development Innovations, LLC 60
Not applicableUnknownNCT03259009What this trial is testingRAS Mutations in ctDNA and Anti-EGFR reINTROduction in mCRC (RASINTRO)Who this might be right forMetastatic Colorectal Cancer Association des Gastroentérologues Oncologues 73
Testing effectiveness (Phase 2)Study completedNCT00597506What this trial is testingExpanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + EverolimusWho this might be right forColorectal Adenocarcinoma Herbert Hurwitz 50